指南与共识乳腺乳腺X线MR

2018年ACR补充筛查建议对乳腺癌幸存者MRI资格的影响

Impact of the 2018 ACR Supplemental Screening Recommendations on MRI Eligibility in Breast Cancer Survivors.
指南 / 共识 · J Am Coll Radiol · 2022-12-11

该回顾性研究基于城市学术医学中心2020年7月至2021年7月的电子健康记录,评估有乳腺癌个人史(PHBC)患者根据2018年ACR建议接受补充乳腺MRI的资格。在2950例自我报告PHBC的患者中,1805例(61%)符合2018年标准,而根据2018年前指南仅3.6%符合,潜在资格增加15倍。

要点

  • 2018年ACR建议使有乳腺癌个人史者补充MRI资格从3.6%升至61%。
  • 新标准纳入致密乳腺组织或50岁前诊断者,不限于遗传基因突变携带者。
  • 日常报告中需关注患者乳腺密度和首诊年龄以判断MRI补充筛查资格。

局限性

  • 单中心回顾性研究,数据来自自我报告的个人史,可能存在回忆偏倚。
  • 未报告乳腺密度和基因突变状态的详细分布及设备参数。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: The 2018 ACR recommendations for breast cancer screening in women at higher than average risk include new recommendations for supplemental breast MRI for patients with personal histories of breast cancer (PHBCs) who carry hereditary cancer gene mutations, have dense breast tissue, or were diagnosed before 50 years of age. In comparison, prior guidelines recommended supplemental MRI only for women with PHBCs who carried hereditary cancer gene mutations. The aim of this study was to quantify the increase in the number of patients with breast cancer for whom supplemental breast MRI would now be recommended.

METHODS: Data were extracted from the electronic health records of patients presenting for screening or diagnostic mammography at an urban academic medical center between July 20, 2020, and July 19, 2021. Data extracted included patient-reported PHBC, age at time of breast cancer diagnosis, and hereditary cancer gene mutation carrier status. Descriptive statistics are reported, evaluating the rate of eligibility for supplemental breast MRI in a retrospective population given the new ACR guidelines.

RESULTS: Of the 2,950 patients with self-reported PHBCs who presented for breast cancer screening in the year between July 2020 and July 2021, 1,805 (61%) met the criteria for supplemental breast MRI according to the 2018 guidelines compared with only 3.6% using pre-2018 guidelines.

CONCLUSIONS: Measuring the impact of the 2018 ACR supplemental MRI recommendations using real-world data at a single urban academic medical center demonstrated a 15-fold increase in potential eligibility for supplemental breast MRI in patients with PHBCs.

来源:J Am Coll Radiol,查看原文。版权归原作者所有。

引用

  1. Lieberenz, Levy, Alvarado, et al. Impact of the 2018 ACR Supplemental Screening Recommendations on MRI Eligibility in Breast Cancer Survivors. J Am Coll Radiol. 2022. PMID: 36516954. doi:10.1016/j.jacr.2022.11.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。